ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q3 2025 Earnings Call Transcript March 28, 2025
ImmunoPrecise Antibodies Ltd. reports earnings inline with expectations. Reported EPS is $-0.06 EPS, expectations were $-0.06.
Operator: Good morning, ladies and gentlemen, and thank you for joining us today for ImmunoPrecise Antibodies Third Quarter Fiscal Year 2025 Earnings Call. We appreciate your time and interest in IPA. Today’s call will be led by our CEO, Dr. Jennifer Bath; and Interim CFO, Joe...
